Endo targets 2020 for launch of cellulite treatment - PharmaLive (press release)

 
 
Endo targets 2020 for launch of cellulite treatmentPharmaLive (press release)icon_facebook · icon_twitter · icon_linkedin · icon_rss · Marketing & Advertising · R&D · Therapeutics · Resources · Manny Awards · Events · Issue Archives · Login · Advertise · PharmaLive > R&D > Clinical Trials > Endo targets 2020 for launch of ...
 
Related NewsFeeds

Sunesis Pharmaceuticals, Inc. (SNSS) Expected to Announce Quarterly Sales of $230,000.00  Fairfield CurrentAnalysts predict that Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) will announce sales of $230

6 visits

In Vitro Lung Model Market 2019 Competition News, Trends and Forecast by 2025  Current News MagazineIndustryResearch.co experts study on "Global In Vitro Lung Model Market by Manufacturers, Applicatio

7 visits

Rigel Pharmaceuticals, Inc. (RIGL) Receives Consensus Recommendation of "Buy? from Brokerages  Fairfield CurrentRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has been assigned a consensus recommendation o

0 visits

The Seven Steps to Avoid Heart Disease Also Critical in Diabetes Prevention  Action News NowThe study found that healthy adults who followed at least four of the seven guidelines were 80 percent less

0 visits

Zynerba Pharmaceuticals (ZYNE) Upgraded by Zacks Investment Research to Buy  PressOracleZacks Investment Research upgraded shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) from a hold rating to a buy r

0 visits

Rhythm Pharmaceuticals (NASDAQ:RYTM) Upgraded by BidaskClub to Strong-Buy  Fairfield CurrentRhythm Pharmaceuticals (NASDAQ:RYTM) was upgraded by analysts at BidaskClub from a "buy? rating to a "strong

0 visits

"DiaCare? national diabetes survey to get underway in Iran  Tehran TimesTEHRAN - A national diabetes survey entitled "DiaCare? will come on stream in Iran, aiming to combat and prevent the adverse eff

1 visits

Iran to hold first national online project Olympiad  Tehran TimesTEHRAN-The first round of online project Olympiad will be held in Iran in the next Iranian calendar year (starting on March 21), Fateme

0 visits

Head-To-Head Review: Polydex Pharmaceuticals (POLXF) and Hydrogenics (NASDAQ:HYGS)  Fairfield CurrentHydrogenics (NASDAQ:HYGS) and Polydex Pharmaceuticals (OTCMKTS:POLXF) are both small-cap oils/energ

1 visits

Invesco DWA Utilities Momentum ETF (PTE) Lowered to Sell at Zacks Investment Research  Fairfield CurrentZacks Investment Research downgraded shares of Invesco DWA Utilities Momentum ETF (NYSE:PTE) fro

0 visits

Heady Investors are Taking a Look at Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)  Weston Business ReviewSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) stock is pricing at $5.78 after moving -4.46% thus far

0 visits

Is Now the Time to Capitalize on Dova Pharmaceuticals, Inc. (:DOVA) Shares?  Weston Business ReviewDova Pharmaceuticals, Inc. (:DOVA) stock is pricing at $8.23 after moving 0.98% thus far this session

0 visits

TRACON Pharmaceuticals (TCON) Stock Price Down 9.4%  Fairfield CurrentTRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded down 9.4% during mid-day trading on Friday . The company traded as low as $

0 visits

Rexahn Pharmaceuticals (RNN) Stock Price Down 9.4%  Fairfield CurrentShares of Rexahn Pharmaceuticals, Inc. (NYSEAMERICAN:RNN) fell 9.4% during mid-day trading on Friday . The stock traded as low as $

0 visits

Peer support sessions for diabetes patients | Clevedon, Portishead and Nailsea news  North Somerset TimesA support group for people with diabetes in Nailsea is raising awareness about the complication

0 visits

Zacks: Analysts Anticipate Alexion Pharmaceuticals, Inc. (ALXN) Will Announce Earnings of $1.83 Per Share  Fairfield CurrentEquities research analysts expect Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN

0 visits

Critical Analysis: Aeon Global Health (AGHC) & Celcuity (CELC)  Fairfield CurrentAeon Global Health (OTCMKTS:AGHC) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the sup

0 visits

TNF Inhibitors Market Manufactures Segment Analysis 2019-2025 (Pfizer,Novartis,Boehringer Ingelheim,Amgen,BioPharma,Mochida Pharmaceutical,Hanall,)  regionnewsonline.comIndustryResearch.co experts stu

0 visits

Sartorius Stedim Biotech S.A. (ENXTPA:DIM): Investors Poring into The Details on the Shares as EV Hits 8342211  Weston Business ReviewSartorius Stedim Biotech S.A. (ENXTPA:DIM) presently has an EV or

0 visits

Agios Pharmaceuticals (AGIO) Raised to "Buy? at BidaskClub  Fairfield CurrentBidaskClub upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO) from a hold rating to a buy rating in a research report r

0 visits

 
Semiconductor Analytics